Q4 2022 EPS Estimates for Invacare Co. (NYSE:IVC) Cut by Oppenheimer

Invacare Co. (NYSE:IVCGet Rating) – Equities researchers at Oppenheimer decreased their Q4 2022 EPS estimates for Invacare in a research report issued to clients and investors on Monday, November 7th. Oppenheimer analyst M. Nirenberg now expects that the health services provider will earn ($0.55) per share for the quarter, down from their previous estimate of ($0.26). The consensus estimate for Invacare’s current full-year earnings is ($1.92) per share. Oppenheimer also issued estimates for Invacare’s FY2023 earnings at ($1.34) EPS and FY2024 earnings at ($0.65) EPS.

Invacare (NYSE:IVCGet Rating) last announced its quarterly earnings data on Monday, August 8th. The health services provider reported ($0.53) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.44) by ($0.09). The firm had revenue of $189.02 million for the quarter, compared to analyst estimates of $212.59 million. Invacare had a negative return on equity of 32.45% and a negative net margin of 9.99%. During the same quarter in the previous year, the company earned ($0.28) earnings per share.

Separately, StockNews.com began coverage on shares of Invacare in a research note on Wednesday, October 12th. They issued a “hold” rating for the company.

Invacare Trading Up 6.1 %

IVC opened at $0.52 on Thursday. The company’s 50 day moving average is $0.79 and its 200-day moving average is $1.05. Invacare has a 1-year low of $0.48 and a 1-year high of $4.48. The company has a current ratio of 1.39, a quick ratio of 0.78 and a debt-to-equity ratio of 2.52. The company has a market cap of $18.54 million, a P/E ratio of -0.24 and a beta of 0.49.

Institutional Investors Weigh In On Invacare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Brandes Investment Partners LP increased its position in shares of Invacare by 77.7% during the first quarter. Brandes Investment Partners LP now owns 33,890 shares of the health services provider’s stock valued at $48,000 after buying an additional 14,820 shares during the period. UBS Group AG increased its position in shares of Invacare by 200.6% in the first quarter. UBS Group AG now owns 37,537 shares of the health services provider’s stock worth $53,000 after purchasing an additional 25,048 shares during the last quarter. Fairhaven Wealth Management LLC bought a new position in shares of Invacare in the first quarter worth approximately $54,000. Hsbc Holdings PLC bought a new position in shares of Invacare in the first quarter worth approximately $54,000. Finally, Virtu Financial LLC bought a new position in shares of Invacare in the first quarter worth approximately $62,000. 69.50% of the stock is currently owned by institutional investors.

Invacare Company Profile

(Get Rating)

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the PinDot brand.

See Also

Earnings History and Estimates for Invacare (NYSE:IVC)

Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.